Table 1 Demographic and clinical characteristics for the total sample and differences between younger (< 60, n = 263) and older (≥ 60, n = 330) patients
Characteristic | Total (%) | Age group | p-value | Post hoc contrasts | |||
|---|---|---|---|---|---|---|---|
< 60 (%) | ≥ 60 (%) | < 60 (%) | ≥ 60 (%) | p-value | |||
Study project | Â | Â | Â | Â | Â | Â | Â |
 Fatigue, Pain, and Sleep | 28.8 | 28.9 | 28.8 | .170 |  |  |  |
 Symptom Prevalence | 34.4 | 38.0 | 31.5 |  |  |  |  |
 Symptom Clusters | 36.8 | 33.1 | 39.7 |  |  |  |  |
Gender- Female | 54.6 | 70.7 | 41.8 | < .001 | Â | Â | Â |
Lives alone | 26.4 | 24.0 | 28.2 | .260 | Â | Â | Â |
Partnered/married | 60.9 | 57.3 | 63.7 | .126 | Â | Â | Â |
Education – Post high school | 61.4 | 68.8 | 55.5 | .001 |  |  |  |
Diagnosis | Â | Â | Â | Â | Â | Â | Â |
 Breast | 33.6 | 48.3 | 21.8 |  | 48.3 | 21.8 | .0125 |
 Prostate | 26.0 | 11.0 | 37.9 | < .001 | 11.0 | 37.9 | .0125 |
 Lung | 13.2 | 11.4 | 14.5 |  |  |  |  |
 Other | 27.3 | 29.3 | 25.8 |  |  |  |  |
Metastases | 34.9 | 37.3 | 32.9 | .297 | Â | Â | Â |
Treatment | Â | Â | Â | Â | Â | Â | Â |
 None | 15.5 | 13.3 | 17.3 |  |  |  |  |
 Only radiation | 43.6 | 33.8 | 51.4 | < .001 | 33.8 | 51.4 | .0125 |
 Only chemotherapy | 27.4 | 31.2 | 24.3 |  |  |  |  |
 Both | 13.5 | 21.7 | 7.0 |  | 21.7 | 7.0 | .0125 |
ECOG Performance Status | Â | Â | Â | Â | Â | Â | Â |
 Fully active | 21.4 | 15.8 | 26.0 |  | 15.8 | 26.0 | .0100 |
 Ambulatory, light work | 48.9 | 53.1 | 45.5 | .043 |  |  |  |
 Ambulatory, mobile > 50% | 21.6 | 23.5 | 20.1 |  |  |  |  |
 Ambulatory, mobile < 50% | 7.2 | 6.5 | 7.7 |  |  |  |  |
 Disabled | 0.9 | 1.2 | 0.6 |  |  |  |  |
Age (years; mean (standard deviation)) | 61.3 (12.1) | 50.3 (7.7) | 70.1 (6.5) | < .001 | Â | Â | Â |